Fed Govt to hand pharmacists $2 billion in compensation for 60-day dispensing
Pharmacies will receive an extra $4.79 per 60-day script dispensed under a new funding agreement with the Federal Government, which has patched up its fractured…
Tag: PBS
‘Regrettable, if understandable’: PBS tightens GLP-1 RA prescribing rules
Doctors prescribing GLP-1 receptor agonists now require telephone or electronic authority when initiating therapy for all PBS indications. On 1 June, health officials tightened the…
Hacked GP prescription data for sale on digital black market for just $76,000: reports
Prescription software company MediSecure says historical prescription data that were hacked earlier this month have been put up for sale on the dark web. According…
The 2024 health budget — the big announcements
There were a lot of pieces in last night’s federal budget, even if nothing was on the scale of the $3.5 billion for bulk-billing incentives…
Viagra is subsidised for veterans, so why is the safest MHT for my heroic patient missing from the PBS?
I want to tell you about a modern-day heroine who has allowed me to share her story. I feel privileged that she is one of my…
Welcome to AusDoc’s new drugs and guidelines update for GPs
Welcome to AusDoc’s drugs and guidelines update for GPs — your newest resource from AusDoc. This concise reference is designed to make it easier to…
PBAC rejects Cushing’s syndrome treatment again
The PBAC has rejected a twice-daily medication for Cushing’s syndrome for the second time because of its cost, despite acknowledging it was an effective therapy…
New endometriosis and diabetes treatments earn PBAC approval
A new endometriosis treatment has been given the PBS green light just three months after it was approved by the TGA. The once-daily combination pill…
Empagliflozin added to PBS for CKD, with or without diabetes
Adults with proteinuric chronic kidney disease can now access PBS-subsidised empagliflozin, regardless of their diabetes status, in addition to standard care. On Monday, 10mg empagliflozin…
‘Set-and-forget’ cholesterol-busting drug now on the PBS
The potent cholesterol-busting drug inclisiran is now subsidised for adults with hypercholesterolaemia who fail to respond to or tolerate statins and ezetimibe. Inclisiran (Leqvio) —…
